Arjun Channi

Arjun Channi is currently the Director of Global Regulatory Affairs at Sanofi, overseeing regulatory strategies for various Early and Late Stage Rare Disorders. With extensive experience in regulatory affairs across multiple therapeutic areas, Arjun has successfully led global teams and negotiated with health authorities worldwide. Prior to this role, Arjun served as an Associate Director at Sanofi and has held positions at RB and Ranbaxy, contributing to regulatory management and compliance for a range of pharmaceutical products. Arjun holds a Master’s degree in Pharmaceutical Technology from King's College London and a Bachelor's degree in Pharmaceutical Sciences from Rayat Institute of Pharmacy.